바이오해킹 시장(2026-2030년)

The global biohacking market is forecasted to grow by USD 96099.8 mn during 2025-2030, accelerating at a CAGR of 20.5% during the forecast period. The report on the global biohacking market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising consumer demand for personalized health and longevity, technological convergence of biotechnology and ai, increasing prevalence of chronic stress and cognitive demands.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global biohacking market is segmented as below:

By Product

• Wearables
• Smart drugs

By Application

• Forensic science
• Synthetic biology
• Genetic engineering
• Others

By End-User

• Pharma and biotech companies
• Forensic laboratories
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Asia
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of generative ai in personalized biological modeling as one of the prime reasons driving the global biohacking market growth during the next few years. Also, proliferation of implantable biotelemetry and subdermal enhancement and convergence of nutrigenomics and epigenetic reprogramming will lead to sizable demand in the market.

The report on the global biohacking market covers the following areas:

• Global biohacking market sizing
• Global biohacking market forecast
• Global biohacking market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biohacking market vendors that include Biohacked Inc., Biostrap USA LLC, Bulletproof 360 Inc., Eight Sleep Inc., Elysium Health Inc., Halo Neuro Inc., Health Via Modern Nutrition Inc., InteraXon Inc., Klean Athlete, Levels Health Inc., Lief Therapeutics Inc., MetaFlow Ltd., Neurohacker Collective LLC, Nutrigenomix Inc., Onnit Labs Inc., Oura Health Oy, Segterra Inc., Thorne HealthTech Inc., Viome Life Sciences Inc., WHOOP Inc.. Also, the global biohacking market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Biohacking Market 2020 - 2024
  • Historic Market Size - Data Table on Global Biohacking Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on global biohacking market
• 6.2 Impact of geopolitical conflict on global biohacking market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Wearables - Market size and forecast 2025-2030
• 8.4 Smart drugs - Market size and forecast 2025-2030
• 8.5 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Forensic science - Market size and forecast 2025-2030
• 9.4 Synthetic biology - Market size and forecast 2025-2030
• 9.5 Genetic engineering - Market size and forecast 2025-2030
• 9.6 Others - Market size and forecast 2025-2030
• 9.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Pharma and biotech companies - Market size and forecast 2025-2030
• 10.4 Forensic laboratories - Market size and forecast 2025-2030
• 10.5 Others - Market size and forecast 2025-2030
• 10.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Asia - Market size and forecast 2025-2030
  • 12.4.1 China - Market size and forecast 2025-2030
  • 12.4.2 India - Market size and forecast 2025-2030
  • 12.4.3 Japan - Market size and forecast 2025-2030
  • 12.4.4 South Korea - Market size and forecast 2025-2030
  • 12.4.5 Indonesia - Market size and forecast 2025-2030
  • 12.4.6 Thailand - Market size and forecast 2025-2030
• 12.5 Europe - Market size and forecast 2025-2030
  • 12.5.1 Germany - Market size and forecast 2025-2030
  • 12.5.2 UK - Market size and forecast 2025-2030
  • 12.5.3 France - Market size and forecast 2025-2030
  • 12.5.4 Italy - Market size and forecast 2025-2030
  • 12.5.5 Spain - Market size and forecast 2025-2030
  • 12.5.6 The Netherlands - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising consumer demand for personalized health and longevity
  • Technological convergence of biotechnology and AI
  • Increasing prevalence of chronic stress and cognitive demands
• 13.2 Market challenges
  • Complex and evolving regulatory frameworks
  • High cost of advanced technologies and data security risks
  • Ethical concerns and social acceptance of human augmentation
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of generative AI in personalized biological modeling
  • Proliferation of implantable biotelemetry and subdermal enhancement
  • Convergence of nutrigenomics and epigenetic reprogramming

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Biohacked Inc.
  • Biohacked Inc. - Overview
  • Biohacked Inc. - Product / Service
  • Biohacked Inc. - Key offerings
  • SWOT
• 15.5 Bulletproof 360 Inc.
  • Bulletproof 360 Inc. - Overview
  • Bulletproof 360 Inc. - Product / Service
  • Bulletproof 360 Inc. - Key offerings
  • SWOT
• 15.6 Elysium Health Inc.
  • Elysium Health Inc. - Overview
  • Elysium Health Inc. - Product / Service
  • Elysium Health Inc. - Key offerings
  • SWOT
• 15.7 Health Via Modern Nutrition Inc.
  • Health Via Modern Nutrition Inc. - Overview
  • Health Via Modern Nutrition Inc. - Product / Service
  • Health Via Modern Nutrition Inc. - Key offerings
  • SWOT
• 15.8 InteraXon Inc.
  • InteraXon Inc. - Overview
  • InteraXon Inc. - Product / Service
  • InteraXon Inc. - Key offerings
  • SWOT
• 15.9 Klean Athlete
  • Klean Athlete - Overview
  • Klean Athlete - Product / Service
  • Klean Athlete - Key offerings
  • SWOT
• 15.10 Lief Therapeutics Inc.
  • Lief Therapeutics Inc. - Overview
  • Lief Therapeutics Inc. - Product / Service
  • Lief Therapeutics Inc. - Key offerings
  • SWOT
• 15.11 MetaFlow Ltd.
  • MetaFlow Ltd. - Overview
  • MetaFlow Ltd. - Product / Service
  • MetaFlow Ltd. - Key offerings
  • SWOT
• 15.12 Nutrigenomix Inc.
  • Nutrigenomix Inc. - Overview
  • Nutrigenomix Inc. - Product / Service
  • Nutrigenomix Inc. - Key offerings
  • SWOT
• 15.13 Onnit Labs Inc.
  • Onnit Labs Inc. - Overview
  • Onnit Labs Inc. - Product / Service
  • Onnit Labs Inc. - Key offerings
  • SWOT
• 15.14 Oura Health Oy
  • Oura Health Oy - Overview
  • Oura Health Oy - Product / Service
  • Oura Health Oy - Key offerings
  • SWOT
• 15.15 Segterra Inc.
  • Segterra Inc. - Overview
  • Segterra Inc. - Product / Service
  • Segterra Inc. - Key offerings
  • SWOT
• 15.16 Thorne HealthTech Inc.
  • Thorne HealthTech Inc. - Overview
  • Thorne HealthTech Inc. - Product / Service
  • Thorne HealthTech Inc. - Key offerings
  • SWOT
• 15.17 Viome Life Sciences Inc.
  • Viome Life Sciences Inc. - Overview
  • Viome Life Sciences Inc. - Product / Service
  • Viome Life Sciences Inc. - Key offerings
  • SWOT
• 15.18 WHOOP Inc.
  • WHOOP Inc. - Overview
  • WHOOP Inc. - Product / Service
  • WHOOP Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations